and

dehydration,
vomiting,
diarrhea);
excessive
hypotension
may occur.
• Reduce
dosage
in
patients
with
impaire
d renal
function
.

74
 DRUG STUDY

Patient: X Medical diagnosis: Cellulitis in right lower extremity and Diabetes Melllitus type 2.
Address: Bitaog, Bansalan, Davao Su Attending physician: Dr. Sarno
Age: 79 yrs. Chief complaint: Wound Swelling at Right Leg

DAT GENER BRAND CLASSIFICAT ACTION INDICATION CONTRA- ROUTE NURSING

E IC NAME ION INDICATION & RESPONSIBILIT
NAME DOSAGE IES
O Rhoxa- Analgesic, anti- Chemical • Osteoarthritis • Contraindica 500mg 1 • Assess
X Oxaprozi inflammatory effect: may , rheumatoid ted in tab. patients
A nl, inhibit arthritis. patients condition
J P Daypro, prostaglan Adults: 1,200 mg hypersensiti TID before
A R Daypro din P.O. once daily. ve to the starting
N O ALTA, synthesis. Divide doses in drug or any therapy,
U Z patients unable to of its and
A I Therapeuti tolerate single components regularly
R N c effect: doses. For and in those thereafter
Y Relieves Osteoarthritis with to monitor
P pain, fever, patients with low syndrome of the drug’s
2 O and body weight and nasal polyps, effectivene
7, T inflammati milder disease, angioedema, ss.
2 A on. give an and • Monitor
0 S initialdose of 600 broncospatic liver
1 S mg once daily. reactions to function
0 I Maximum daily aspirin or test results
I dose 1,800 mg. other periodicall
M NSAIDs. y during

75
• Use long-term
cautiously in therapy,
patients with and
history of closely
peptic ulcer monitor
disease, patient
hepatic or with
renal abnormal
dysfunction, test results.
hypertension Liver
, CV function
disease, or values
conditions may be
that elevated.
predispose These
to fluid abnormal
retention. findings
may
persist,
worsen, or
resolve
with
continued
therapy.
Rarely,
patient
may
progress to
severe
hepatic
dysfunctio
n.
• Be alert

76
for adverse

75